# HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option

> **NCT02934282** · — · NO_LONGER_AVAILABLE · sponsor: **Mauricio Lynn**

## Conditions studied

- Anemia

## Interventions

- **DRUG:** HBOC-201

## Key facts

- **NCT ID:** NCT02934282
- **Lead sponsor:** Mauricio Lynn
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2024-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934282, "HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02934282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*